day 8 the research-driven part of "multi-disciplinary research-driven care"
The other key component of the care delivered at MD Anderson is that it is research driven. To me that means two things. First, it means that our physicians are all academic, and strongly connected...
View Articleday 20 the nitty gritty of personalized medicine for breast cancer
You read a lot about personalized cancer therapy both in scientific journals and in the general press. The idea is that in the (near) future doctors will be able to learn a lot more information about...
View Articleday 42 a doctor with heart or why a cancer center has cardiologists
On day 38 I wrote about side effects and how they tell you things are working. Well, there are some that overshoot that mark a little, and can cause real harm. While no side effects are great, many are...
View Articleday 79 Tamoxifen: 5 years good, 10 years better
A new study of the impact of long-term hormone treatment using Tamoxifen, which was presented this week as the San Antonio Breast Cancer Symposium (www.sabcs.org), showed that 10 years was...
View Articlemen are eligible for only 1 in 3 breast cancer clinical trials
In a recent post I discussed the underfunding of basic research on the male form of breast cancer, and advocated for 1% of breast cancer research funding to involve male disease, in proportion to 1% of...
View Articleday 268 – I am getting ready to join an immunotherapy trial to prevent...
In another month or so, I am joining an immunotherapy clinical trial that is aimed at suppressing recurrence, by training the immune system to pay attention to cancer cells more effectively. It is a...
View Articleday 30 – why joining tissue studies is vital to ushering in the era of...
Earlier this week I blogged about the cancer conference, the WIN Symposium which I attended last week. I summarized some of the current challenges in developing personalized cancer therapies, including...
View ArticleEORTC, BIG and NABCG follow international retrospective male breast cancer...
I am very excited about this new prospective study of male breast cancer that was just announced. As the press release (below) states: “The second part of this Program, which is now open, is a...
View Articlearomatase inhibitors work for #malebreastcancer according to Zagouri et al –...
Aromatase inhibitors in male breast cancer: a pooled analysis Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T Breast Cancer Res Treat. 2015 May;151(1):141-7. doi:...
View Articlehow much benefit you get from tamoxifen for #malebreastcancer depends on how...
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Abreu MH, Gomes M, Menezes F, Afonso N, Abreu PH, Medeiros R, Pereira D, Lopes C. Breast. 2015 Aug;24(4):481-6....
View Articleday 1025: Thanks to @ArmyofWomen I’m joining a trial to help with chemo...
I have been very fortunate – its been nearly three years since my diagnosis and I am NED (no evidence of disease, or the solid tumor equivalent of remission which is more commonly used for liquid...
View Article
More Pages to Explore .....